View More Recent Stories

Oct 3, 2016 11:27AM Dermira (DERM) Shares Rise as CIMZIA Phase 3 Met co-Primary Efficacy Endpoints in Plaque Psoriasis
Oct 3, 2016 02:00AM CIMZIA® (certolizumab pegol) Phase 3 Trial Meets Co-primary Efficacy Endpoints in Patients with Moderate-to-Severe Chronic Plaque Psoriasis
View More Recent Stories